Lantheus Holdings (LNTH) Change in Account Payables (2014 - 2026)
Lantheus Holdings (LNTH) reported Change in Account Payables of $190000.0 for Q1 2026, down 96.19% year-over-year from $5.0 million in Q1 2025, and up 100.59% quarter-over-quarter from -$32.0 million in Q4 2025.
Lantheus Holdings (LNTH) Change in Account Payables (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Change in Account Payables data on file, last reported at $190000.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $190000.0, down 96.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.3 million (down 1923.33% YoY), and the FY2025 annual result was -$2.5 million, up 71.69% from the prior year.
- Change in Account Payables advanced to $190000.0 in Q1 2026 per LNTH's latest filing, from -$32.0 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $20.1 million in Q3 2025 and troughed at -$32.0 million in Q4 2025.
- A 5-year average of $375529.4 and a median of $1.5 million in 2022 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 933.63% in 2022 and fell as far as 1349.31% in 2022.
- A 5-year view of Change in Account Payables shows it stood at -$8.1 million in 2022, then jumped by 162.15% to $5.0 million in 2023, then plunged by 297.56% to -$10.0 million in 2024, then tumbled by 221.09% to -$32.0 million in 2025, then surged by 100.59% to $190000.0 in 2026.
- Business Quant data shows LNTH's Change in Account Payables at $190000.0 in Q1 2026, -$32.0 million in Q4 2025, and $20.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 190,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 167.64 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,000.00 |
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | -31.97 Mn |
| Dec 31, 2025 | -31.97 Mn |
| Sep 30, 2025 | 20.11 Mn |
| Sep 30, 2025 | 20.11 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | 4.98 Mn |
| Mar 31, 2025 | 4.98 Mn |
| Dec 31, 2024 | -9.96 Mn |
| Dec 31, 2024 | -9.96 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Jun 30, 2024 | 10.34 Mn |
| Jun 30, 2024 | 10.34 Mn |
| Mar 31, 2024 | -3.46 Mn |
| Mar 31, 2024 | -3.46 Mn |
| Dec 31, 2023 | 5.04 Mn |
| Dec 31, 2023 | 5.04 Mn |